A recent study highlights the need for expanded cancer coverage and early diagnosis under Ayushman Bharat, revealing ...
The escalating war in Iran is raising concerns over potential drug shortages and price hikes in Nigeria, as disruptions to ...
Study to test RC220 alongside standard-of-care osimertinib to prevent or delay treatment resistance. ... Read More The post ...
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first healthy volunteer has been ...